DrugPatentWatch Database Preview
Mylan Pharms Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?
MYLAN PHARMS INC has one hundred and nineteen approved drugs.
There are sixteen tentative approvals on MYLAN PHARMS INC drugs.
Summary for Mylan Pharms Inc
| US Patents: | 0 |
| Tradenames: | 105 |
| Ingredients: | 103 |
| NDAs: | 119 |
Drugs and US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 202640-001 | Sep 17, 2012 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | EPROSARTAN MESYLATE | eprosartan mesylate | TABLET;ORAL | 202012-002 | Nov 16, 2011 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 200913-002 | Mar 25, 2013 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | FLUVASTATIN SODIUM | fluvastatin sodium | CAPSULE;ORAL | 090595-002 | Apr 11, 2012 | AB | RX | No | Yes | Start Trial | Start Trial | ||||
| Mylan Pharms Inc | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077037-003 | Nov 5, 2004 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 079187-003 | May 27, 2010 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | PIOGLITAZONE HYDROCHLORIDE | pioglitazone hydrochloride | TABLET;ORAL | 076801-002 | Aug 17, 2012 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | Start Trial |
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | Start Trial |
| Mylan Pharms Inc | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | Start Trial |
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 4,971,800 | Start Trial |
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 5,045,317 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
